今年我国已批准十余款创新药,跨国药企探索多元化合作模式

第一财经
Apr 12

国家药监局日前公布的最新数据显示,今年截至4月10日,国家药监局已批准上市了13款创新药,这些药物的治疗领域从抗肿瘤到降血糖、降血脂,覆盖多种关键疾病,其中包括6款首创新药(first-in-class药物)。  就在4月10日,百济神州宣布治疗小细胞肺癌的药物塔拉妥单抗(商品名:安泰适)经优先审评程序获得国家药品监督管理局附条件批准,该药物是全球唯一一个获批的靶向DLL3和CD3的双特异性T细胞...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10